Related Funds
Fund Name | Location |
ACT | Iowa, Iowa City, United States |
Azimuth Opportunity | New York, New York, United States |
DRW Venture Capital | Chicago, Illinois, United States |
ES NETWORKS | Japan, Tokyo |
Hengqin Zanlu Equity Investment Fund | - |
Heyokha Brothers | China, Hong Kong, Hong Kong Island |
Hua Partners | China, Guangdong, Shenzhen |
Kakao Pay | Cheju-do, Jeju, South Korea |
MetaProp NYC | New York, New York, United States |
Monstar Lab | Japan, Tokyo |
N-tech | Ahmedabad, Gujarat, India |
New Asia Partners | - |
NextWave Ventures | California, San Diego, United States |
Ontario Scale-Up Vouchers Program (OSVP) | - |
Orange Fab | California, San Francisco, United States |
Portuguese Public Funding | - |
Roche Venture Fund | Basel, Basel-Stadt, Switzerland |
Symmetry Peak Management | Pennsylvania, Radnor, United States |
The Renewable Energy Corporation | Central, Central Region, Singapore |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Jingyuyimei | 18 Jun 2024 | Fangshan, Beijing, China | |||
Monyan Pharma | $15M | 13 Nov 2023 | Hubei, China | ||
Baiying Bio | $77M | 31 Aug 2022 | Dongcheng District, Beijing, China | ||
Juncell Therapeutics | 15 Jan 2022 | Jiading, Shanghai, China | |||
Svolt Energy Technology Co. | 22 Mar 2021 | Baoding City, Hebei, China | |||
QXQ Technology | $37M | 10 Sep 2020 | Shanghai, China | ||
Primeton | $7M | 26 Mar 2019 | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Jingyuyimei | 18 Jun 2024 | Fangshan, Beijing, China | |||
Monyan Pharma | $15M | 13 Nov 2023 | Hubei, China | ||
Baiying Bio | $77M | 31 Aug 2022 | Dongcheng District, Beijing, China | ||
Juncell Therapeutics | 15 Jan 2022 | Jiading, Shanghai, China | |||
Svolt Energy Technology Co. | 22 Mar 2021 | Baoding City, Hebei, China | |||
QXQ Technology | $37M | 10 Sep 2020 | Shanghai, China | ||
Primeton | $7M | 26 Mar 2019 | China, Shanghai |